Resource Centre
Trial of Lopinavir–Ritonavir in Adults Hospitalised with Severe COVID-19
April 21, 2020
![](https://aslm.org/wp-content/uploads/2020/04/Lopinavir–Ritonavir.jpg?x12179)
This study by Dr Bin Cao, et al, 2020, in the New England Journal of Medicine describes a trial of lopinavir–ritonavir in adults hospitalised with severe COVID-19 where no benefit was observed with this treatment beyond standard care.